Developer docs
API playgroundTry for free, no card

Search company profiles

Elife Sciences

Full company profile

uuid000mzuc

Namestring
Elife Sciences
Legal namestring
eLife Sciences Publications, Ltd
Company typeenum
Private
Founded yearint
2012
Descriptiontext

eLife Sciences (legal entity: eLife Sciences Publications, Ltd) is a 501(c)(3) nonprofit open-access publisher focused on life sciences and biomedical research. Founded in 2011/2012 and headquartered in Cambridge, UK, the organization operates the eLife Journal, which since January 2023 publishes papers under a "Reviewed Preprints" model: every paper that completes peer review is published alongside public peer reviews and an eLife Assessment summarizing significance (landmark to useful) and strength of evidence (exceptional to inadequate), eliminating the traditional accept/reject outcome after review. The catalog spans 19 subject areas including Cell Biology, Neuroscience, Immunology, and Evolutionary Biology, with content licensed under CC-BY 4.0 and made freely available globally without paywall or registration. Adjacent offerings include the eLife Podcast (e.g., Episode 103, May 2026), a YouTube channel, active Bluesky and Threads presences, and public APIs.

Underlying technology consists of a digital publishing platform with HTML/PDF article rendering, a full XML article corpus distributed via GitHub, open-source publishing software products under permissive licensing, and developer-facing APIs that expose article metadata, peer reviews, and assessments. The architecture is built around open standards (CC-BY 4.0, XML, public APIs) and is designed for adoption by other scholarly publishing initiatives, not just internal use.

The business model is institutional funding rather than transactional revenue. eLife charges no publication fees to authors and no access or subscription fees to readers. Operations are sustained by a coalition of four major biomedical research funders — Howard Hughes Medical Institute (HHMI), Wellcome Trust, Max Planck Society, and the Knut and Alice Wallenberg Foundation — with a disclosed "significant" Wellcome Trust grant in March 2026 earmarked for building an open publishing ecosystem and collaborative publishing tools. The organization employs 51–100 staff, serves a global community of academic researchers, science journalists, and institutional readers, and pursues go-to-market through community-led engagement (academic networks, conferences, editorial reputation) and event-driven media outreach (press releases, podcast episodes).

Short descriptiontext

eLife Sciences is a nonprofit open-access publisher of life sciences and biomedical research, funded by HHMI, Wellcome, Max Planck, and Wallenberg Foundation, serving global academic researchers through a reviewed-preprints model with public peer reviews.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
51–100
akta.pro rankint
HeadquartersCambridge, United Kingdom
HQ citystring
Cambridge
HQ countrystring
United Kingdom
HQ regionstring
Europe
Markets served

Serves global market

Offices2 records

Each record includes

City, Country, Type, Description, Source

Keyword5 values
open access publishing, scientific peer review, biomedical journal, research preprints, scholarly publishing platform
Industry1 code
PRIMARYEDAGAFAC
Life Sciences (Biology, Ecology, Agriculture) Scholarly Publishing
Education/Educational Publishing & Learning Content/Academic & Scholarly Publishing (Journals, Monographs)
NAICS code1 code
  • Book Publishers513130
SIC code1 code
  • Books: Publishing Or Publishing & Printing2731
Product category
Open-Access Scientific Publishing
GTM motion2 records

Each record includes

Type, Description, Source

Revenue model1 record
1Non-profit Organization Funding
TypeSubscription Recurring
Description

eLife Sciences Publications, Ltd is a 501(c)(3) nonprofit organization funded by major research funders. The organization does not charge publication fees to authors and provides open access to all published content free of charge to readers.

elifesciences.org
Marketing channels7 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels2 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Personnel, Technology or R&D, Operations, Marketing or Sales, Infrastructure
GTM typeB2B
B2B
Offering typeDigital Commerce or Conte…
Digital Commerce or Content
Core offering1 text field

Elife Sciences is a nonprofit open-access publisher that operates the eLife Journal, publishing peer-reviewed life sciences and biomedical research articles under a CC-BY 4.0 license. Its core, differentiating service is the Reviewed Preprints model in which papers that complete peer review are published as preprints with public peer reviews and structured eLife Assessments (rating significance and strength of evidence), rather than being accepted or rejected after review. The organization charges no publication fees to authors and no subscription or access fees to readers, and distributes content via its website, open APIs, and an XML corpus on GitHub.

Differentiator
Functional benefit
Problem solved
Product overview1 text field

eLife Sciences operates a comprehensive open-access publishing platform for life sciences and biomedical research. The core offering consists of the eLife Journal, which publishes research articles alongside Reviewed Preprints with public peer reviews and eLife assessments. The organization has introduced a new publishing model that ends the traditional accept-reject decision, instead publishing reviewed preprints with open peer review. Additional offerings include the eLife Podcast, open-source software tools available on GitHub, and the full XML article corpus for research data access. All content is published under Creative Commons Attribution (CC-BY 4.0) license.

Product and service5 records
1eLife Journal
CategoryOpen-Access Scientific Journal
Description

Flagship open-access journal for life sciences and biomedical research that publishes peer-reviewed research articles, insights, feature articles, and editorials under CC-BY 4.0 with no publication or access fees. Targeted at researchers, students, clinicians, and the broader scientific community across 19 subject areas.

2eLife Reviewed Preprints
CategoryPeer-Reviewed Preprint Publishing
Description

Peer-reviewed preprints that have completed eLife's review process and are published with full public peer reviews and an eLife Assessment summarizing significance and strength of evidence, instead of being accepted or rejected. Targeted at life sciences and biomedical researchers seeking rapid open dissemination with transparent peer review.

3eLife Podcast
CategoryScience Podcast
Description

Regular podcast episodes (e.g., Episode 103 in May 2026) featuring discussions of scientific research published in eLife and conversations with researchers and editors. Targeted at the scientific community and science-interested general audience.

4eLife Open Source Software Products
CategoryOpen-Source Publishing Software
Description

Suite of open-source publishing software products developed by eLife and published on its GitHub organization under permissive open-source licenses, intended for adoption by other publishers and the scholarly community to accelerate discovery and transform research communication.

5eLife Article XML Corpus
CategoryResearch Data / Open Corpus
Description

Full corpus of eLife scientific manuscripts published as articles, distributed in XML format for download from the eLife GitHub repository (elife-article-xml) and licensed under CC-BY 4.0, enabling text mining, computational analysis, and reuse by researchers and developers.

Scale indicator3 records

Each record includes

Type, Value, Description, Source

Recent move5 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight5 records

Each record includes

Type, Description

Peers10 records
TypeBroad incumbent
Description

Major legacy publisher of Nature and hundreds of other journals, including open-access titles. Comparable as a broad incumbent in scientific publishing whose portfolio overlaps significantly with eLife's life sciences scope.

TypeDirect peer
Description

Open-access publishing platform using post-publication peer review. Comparable as an open-access, transparent-review model serving life sciences researchers.

TypeDirect peer
Description

Open-access peer-reviewed publisher in the life sciences and medicine, with a member-fee business model. Directly comparable in audience (life sciences researchers) and open-access publishing model.

TypeDirect peer
Description

Large open-access publisher of peer-reviewed life sciences journals, part of Springer Nature. Directly comparable in offering open-access publishing in life sciences and biomedicine.

5Hindawi
TypeDirect peer
Description

Open-access academic publisher (now part of Wiley) covering sciences including life sciences. Comparable as an open-access journal publisher serving similar researcher authors.

TypeDirect peer
Description

Preprint servers operated by Cold Spring Harbor Laboratory for life sciences and clinical research. Comparable because they serve the same researcher audience with rapid, open research sharing, and intersect with eLife's preprint-friendly model.

TypeDirect peer
Description

Nonprofit open-access publisher of peer-reviewed scientific journals across life sciences and medicine. Most direct comparable to eLife given shared nonprofit, open-access, no-fee or low-fee model and similar scientific audience.

8Cell Press (Elsevier)
TypeBroad incumbent
Description

Publisher of Cell and related life sciences journals under Elsevier. Comparable as a broad incumbent publishing peer-reviewed life sciences and biomedical research.

TypeBroad incumbent
Description

Publisher of Science and Science family journals. Comparable as a broad incumbent in scientific publishing competing for the same high-prestige life sciences submissions.

10Wellcome Open Research
TypeDirect peer
Description

Open-access publishing platform funded by Wellcome Trust using post-publication peer review. Highly comparable given shared Wellcome funding, open-access model, and life sciences focus.

Market position
Strengths4 records

Each record includes

Headline, Details, Source

Weaknesses4 records

Each record includes

Headline, Details, Source

Competitive moat5 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers2 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment3 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile2 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
Yes

Docs URL, Description

AI maturity
App detail

Has app

Feature4 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
No data
Compliance1 record

Each record includes

Name, Class, Description

Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Elife Sciences

Open-Access Scientific Publishingelifesciences.org

eLife Sciences is a nonprofit open-access publisher of life sciences and biomedical research, funded by HHMI, Wellcome, Max Planck, and Wallenberg Foundation, serving global academic researchers through a reviewed-preprints model with public peer reviews.

What Elife Sciences does

eLife Sciences (legal entity: eLife Sciences Publications, Ltd) is a 501(c)(3) nonprofit open-access publisher focused on life sciences and biomedical research. Founded in 2011/2012 and headquartered in Cambridge, UK, the organization operates the eLife Journal, which since January 2023 publishes papers under a "Reviewed Preprints" model: every paper that completes peer review is published alongside public peer reviews and an eLife Assessment summarizing significance (landmark to useful) and strength of evidence (exceptional to inadequate), eliminating the traditional accept/reject outcome after review. The catalog spans 19 subject areas including Cell Biology, Neuroscience, Immunology, and Evolutionary Biology, with content licensed under CC-BY 4.0 and made freely available globally without paywall or registration. Adjacent offerings include the eLife Podcast (e.g., Episode 103, May 2026), a YouTube channel, active Bluesky and Threads presences, and public APIs.

Underlying technology consists of a digital publishing platform with HTML/PDF article rendering, a full XML article corpus distributed via GitHub, open-source publishing software products under permissive licensing, and developer-facing APIs that expose article metadata, peer reviews, and assessments. The architecture is built around open standards (CC-BY 4.0, XML, public APIs) and is designed for adoption by other scholarly publishing initiatives, not just internal use.

The business model is institutional funding rather than transactional revenue. eLife charges no publication fees to authors and no access or subscription fees to readers. Operations are sustained by a coalition of four major biomedical research funders — Howard Hughes Medical Institute (HHMI), Wellcome Trust, Max Planck Society, and the Knut and Alice Wallenberg Foundation — with a disclosed "significant" Wellcome Trust grant in March 2026 earmarked for building an open publishing ecosystem and collaborative publishing tools. The organization employs 51–100 staff, serves a global community of academic researchers, science journalists, and institutional readers, and pursues go-to-market through community-led engagement (academic networks, conferences, editorial reputation) and event-driven media outreach (press releases, podcast episodes).

Elife Sciences firmographics

Firmographics
Name
Elife Sciences
Legal name
eLife Sciences Publications, Ltd
Website
https://elifesciences.org
Company type
Private
Founded year
2012
Operating status
Operating
Headcount range
51–100 employees
Short description
eLife Sciences is a nonprofit open-access publisher of life sciences and biomedical research, funded by HHMI, Wellcome, Max Planck, and Wallenberg Foundation, serving global academic researchers through a reviewed-preprints model with public peer reviews.
Ownership category
akta.pro rank

Elife Sciences industry classification

Industry
Product category
Open-Access Scientific Publishing
NAICS
Book Publishers (513130)
SIC
Books: Publishing Or Publishing & Printing (2731)
akta.pro industry
PRIMARYEDAGAFAC
Life Sciences (Biology, Ecology, Agriculture) Scholarly Publishing
Education/Educational Publishing & Learning Content/Academic & Scholarly Publishing (Journals, Monographs)

Keywords

  • Open access publishing
  • Scientific peer review
  • Biomedical journal
  • Research preprints
  • Scholarly publishing platform

Where Elife Sciences is headquartered

Location

Headquarters

HQ city
Cambridge
HQ country
United Kingdom
HQ region
Europe

Offices2 records

Markets served

Elife Sciences business model

Business model
GTM type
B2B
Offering type
Digital Commerce or Content
Cost components
Personnel, Technology or R&D, Operations, Marketing or Sales, Infrastructure

Revenue model

  1. Non-profit Organization Funding: eLife Sciences Publications, Ltd is a 501(c)(3) nonprofit organization funded by major research funders. The organization does not charge publication fees to authors and provides open access to all published content free of charge to readers.

Go-to-market motion2 records

Distribution channels2 records

Marketing channels7 records

Elife Sciences product offering

Product offering

Core offering

Elife Sciences is a nonprofit open-access publisher that operates the eLife Journal, publishing peer-reviewed life sciences and biomedical research articles under a CC-BY 4.0 license. Its core, differentiating service is the Reviewed Preprints model in which papers that complete peer review are published as preprints with public peer reviews and structured eLife Assessments (rating significance and strength of evidence), rather than being accepted or rejected after review. The organization charges no publication fees to authors and no subscription or access fees to readers, and distributes content via its website, open APIs, and an XML corpus on GitHub.

Product overview

eLife Sciences operates a comprehensive open-access publishing platform for life sciences and biomedical research. The core offering consists of the eLife Journal, which publishes research articles alongside Reviewed Preprints with public peer reviews and eLife assessments. The organization has introduced a new publishing model that ends the traditional accept-reject decision, instead publishing reviewed preprints with open peer review. Additional offerings include the eLife Podcast, open-source software tools available on GitHub, and the full XML article corpus for research data access. All content is published under Creative Commons Attribution (CC-BY 4.0) license.

Differentiator

Problem solved

Functional benefit

Products and services

  • eLife Journal Flagship open-access journal for life sciences and biomedical research that publishes peer-reviewed research articles, insights, feature articles, and editorials under CC-BY 4.0 with no publication or access fees. Targeted at researchers, students, clinicians, and the broader scientific community across 19 subject areas.
  • eLife Reviewed Preprints Peer-reviewed preprints that have completed eLife's review process and are published with full public peer reviews and an eLife Assessment summarizing significance and strength of evidence, instead of being accepted or rejected. Targeted at life sciences and biomedical researchers seeking rapid open dissemination with transparent peer review.
  • eLife Podcast Regular podcast episodes (e.g., Episode 103 in May 2026) featuring discussions of scientific research published in eLife and conversations with researchers and editors. Targeted at the scientific community and science-interested general audience.
  • eLife Open Source Software Products Suite of open-source publishing software products developed by eLife and published on its GitHub organization under permissive open-source licenses, intended for adoption by other publishers and the scholarly community to accelerate discovery and transform research communication.
  • eLife Article XML Corpus Full corpus of eLife scientific manuscripts published as articles, distributed in XML format for download from the eLife GitHub repository (elife-article-xml) and licensed under CC-BY 4.0, enabling text mining, computational analysis, and reuse by researchers and developers.

Companies that use Elife Sciences

Customer profile

Named customers2 records

Segments3 records

Ideal customer profiles2 records

Elife Sciences technology and API

Technology

Technology focussed Yes

API detail

Has API
Yes
API docs
API detail

Core technology

AI maturity

App detail

Feature4 records

Elife Sciences partnerships and signals

Strategic signal

Scale indicators3 records

Recent moves5 records

Expansion highlights5 records

Elife Sciences competitors and assessment

Company assessment

Broad incumbents

  • Springer Nature: Major legacy publisher of Nature and hundreds of other journals, including open-access titles. Comparable as a broad incumbent in scientific publishing whose portfolio overlaps significantly with eLife's life sciences scope.
  • Cell Press (Elsevier): Publisher of Cell and related life sciences journals under Elsevier. Comparable as a broad incumbent publishing peer-reviewed life sciences and biomedical research.
  • AAAS (publisher of Science): Publisher of Science and Science family journals. Comparable as a broad incumbent in scientific publishing competing for the same high-prestige life sciences submissions.

Direct peers

  • F1000Research: Open-access publishing platform using post-publication peer review. Comparable as an open-access, transparent-review model serving life sciences researchers.
  • PeerJ: Open-access peer-reviewed publisher in the life sciences and medicine, with a member-fee business model. Directly comparable in audience (life sciences researchers) and open-access publishing model.
  • BioMed Central: Large open-access publisher of peer-reviewed life sciences journals, part of Springer Nature. Directly comparable in offering open-access publishing in life sciences and biomedicine.
  • Hindawi: Open-access academic publisher (now part of Wiley) covering sciences including life sciences. Comparable as an open-access journal publisher serving similar researcher authors.
  • bioRxiv and medRxiv: Preprint servers operated by Cold Spring Harbor Laboratory for life sciences and clinical research. Comparable because they serve the same researcher audience with rapid, open research sharing, and intersect with eLife's preprint-friendly model.
  • PLOS (Public Library of Science): Nonprofit open-access publisher of peer-reviewed scientific journals across life sciences and medicine. Most direct comparable to eLife given shared nonprofit, open-access, no-fee or low-fee model and similar scientific audience.
  • Wellcome Open Research: Open-access publishing platform funded by Wellcome Trust using post-publication peer review. Highly comparable given shared Wellcome funding, open-access model, and life sciences focus.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

Elife Sciences social profiles

Digital presence

Elife Sciences compliance and trust

Trust signal

Compliance1 record

Elife Sciences financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Elife Sciences leadership team

Management profile

Number of profiles

Elife Sciences funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Elife Sciences M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Elife Sciences

What does Elife Sciences do?

Elife Sciences is a nonprofit open-access publisher that operates the eLife Journal, publishing peer-reviewed life sciences and biomedical research articles under a CC-BY 4.0 license. Its core, differentiating service is the Reviewed Preprints model in which papers that complete peer review are published as preprints with public peer reviews and structured eLife Assessments (rating significance and strength of evidence), rather than being accepted or rejected after review. The organization charges no publication fees to authors and no subscription or access fees to readers, and distributes content via its website, open APIs, and an XML corpus on GitHub.

Is Elife Sciences a public or private company?

Elife Sciences is a private company. It is classified as nonprofit foundation owned and is currently operating.

When was Elife Sciences founded?

Elife Sciences was founded in 2012. It employs 51 to 100 people.

Where is Elife Sciences based?

Elife Sciences is headquartered in Cambridge, United Kingdom, in the Europe region.

How does Elife Sciences make money?

One revenue line is on record: non-profit Organization Funding.

Who are Elife Sciences's main competitors?

Broad incumbents on record are Springer Nature, Cell Press (Elsevier) and AAAS (publisher of Science). Direct peers are F1000Research, PeerJ, BioMed Central, Hindawi, bioRxiv and medRxiv, PLOS (Public Library of Science) and Wellcome Open Research.

Does Elife Sciences have an API?

Yes. eLife operates Application Programming Interfaces (eLife APIs) that provide access to scientific manuscripts published on the platform. The full corpus of articles is available in XML format from their GitHub repository (elife-article-xml). The API enables access to article metadata, peer reviews, and eLife assessments. Resources are available under permissive open-source licensing.

What industry is Elife Sciences in?

Elife Sciences's product category is Open-Access Scientific Publishing. Its primary akta.pro industry code is EDAGAFAC, Life Sciences (Biology, Ecology, Agriculture) Scholarly Publishing. Its NAICS code is 513130 and its SIC code is 2731.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
NaturePreprint-centric publishing approach gets major boostThe European Commission will expand its Open Research Europe platform by early November, offering free editorial services to over 2.5 million researchers. The €16 million project, funded 60% by the commission, will host preprints with open peer review. The expansion follows eLife's controversial model, which lost its impact factor within two years.The Times of IndiaVolunteers Revolutionize Tuberculosis Research: Online Citizen Science Project Analyzes Drug ResistanceVolunteers on the Zooniverse platform BashTheBug analyzed images of Mycobacterium tuberculosis samples exposed to antibiotics, identifying bacterial growth patterns. A 2022 eLife study found that aggregated crowd responses improved agreement with expert classifications, suggesting citizen science can help process large volumes of laboratory images.Tamil NewsRete Ovarii: The ‘Useless’ Female Organ That Has The Internet Talking About Misogyny In Medical ResearchA 2024 eLife study found the rete ovarii, a small network of tubes next to the ovary, is biologically active in mice, contradicting its long dismissal as useless. The rediscovery sparked online debate about medical misogyny, as the male equivalent, the rete testis, has a documented role. Researchers say it may support ovarian health, but no link to fertility or disorders has been proven.YahooScientists Say They Were Wrong About This Female Body Part Once Called UselessNew research published in eLife shows the rete ovarii, once dismissed as vestigial, actively pumps fluids and delivers proteins like IGFBP2 to the ovary. The structure, first described in 1870, responds to estrogen and progesterone, suggesting a role in ovarian homeostasis. Scientists caution that mouse studies do not prove it is essential for human fertility.ZME ScienceScientists Reconstruct Videos of What Mice See Straight From Their BrainsNeuroscientists reconstructed moving images from the brain activity of mice by monitoring 8,000 neurons in the visual cortex and using a machine-learning model to match neural signals with video clips. The study, led by Dr. Joel Bauer at University College London, revealed that reconstructions are imperfect, highlighting how the brain actively interprets and warps sensory information rather than recording it passively. Published in eLife, this research provides a new method for studying animal perception, predictive coding, and selective attention.eLifePeer review in Ab initio prediction of specific phospholipid complexes and membrane association of HIV-1 MPER antibodies by multi-scale simulationsResearchers from The Scripps Research Institute published a study in eLife detailing multiscale molecular dynamics simulations that characterize how HIV-1 broadly neutralizing antibodies associate with model lipid bilayers. The study identifies specific phospholipid binding sites and framework regions critical for membrane association, providing a generalized computational framework for understanding antibody-lipid interactions. These findings offer mechanistic insights into how these antibodies drive neutralization, which could inform the design of more potent vaccine candidates.RetractionwatcheLife won’t get an impact factor, says ClarivateClarivate will continue indexing some eLife content in Web of Science but will not assign an Impact Factor. The company will only index articles that pass its 24 quality criteria, excluding those deemed 'incomplete' or 'inadequate.' eLife has not yet responded to Clarivate's letter.NatureStrife at eLife: inside a journal’s quest to upend science publishingeLife announced that from 31 January, it will publish every paper it sends out for peer review, with reviewers' reports and an editorial assessment. Authors can then decide whether to revise the paper to address comments.The GuardianScience journals ban listing of ChatGPT as co-author on papersPublishers of thousands of scientific journals have banned or restricted ChatGPT as a co-author, citing risks of flawed or fabricated research. Science, Springer-Nature, Elsevier, and eLife updated policies, requiring authors to disclose AI use and take responsibility for output.eLifeeLife’s New Model: Changing the way you share your researcheLife will publish peer-reviewed papers as Reviewed Preprints from next year, with public reviews and an eLife assessment. Authors decide whether to revise or declare it as the Version of Record. The model aims to be faster, more transparent, and fairer.